RECENT NEWS

A major international research project, led by the Global Alzheimer's Platform Foundation, is underway to test whether a finger prick-style blood test could be used to help diagnose Alzheimer's disease.

The IBMS Awards celebrate the people, teams and organisations making a real impact across biomedical science. From leadership and innovation to education, collaboration and public engagement, the Awards highlight excellence from across the profession.

Diasorin and QIAGEN have announced the launch of the new CE-marked LIAISON QuantiFERON-TB Gold Plus II, a next-generation assay that redefines speed and throughput as an aid in the diagnosis of tuberculosis infection on LIAISON analyser systems.

A toxin secreted by cholera bacteria can inhibit the growth of colorectal cancer without causing any measurable damage to the body. This is shown by a new study by researchers at Umeå University, Sweden.

A new study has confirmed the novel vaccine being used in global efforts to achieve and sustain polio eradication is successfully interrupting polio outbreaks whilst minimising risk of new vaccine-derived outbreaks in Uganda.

A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies before treatment begins, according to new research.

Join our free exclusive webinar on Friday 30 January at 11am, featuring Debra Padgett and Hugo Craven as they reflect on key lessons from a strategic partnership aimed at optimising specimen reception and pre-analytics.

A new consensus document developed by The Blood Profiling Atlas in Cancer (BLOODPAC) Consortium provides generic protocols for the analytical validation of tumour-informed ctDNA assays for Molecular Residual Disease (MRD) liquid biopsy tests.

The blood transfusion service at Aneurin Bevan University Health Board has gone live with Clinisys WinPath in a first of type deployment in Wales.

Healthcare industry innovator Dr Melanie Ivarsson has been appointed as CEO of the HDRS to accelerate medical breakthroughs.

The MHRA is setting out the next phase of clinical trial reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research.

A new technique which slashes the time taken to diagnose microbial infections from days to minutes could help save lives and open up a new front in the battle against antibiotic resistance, researchers say.

AI-powered pathology firm PathAI has announced a strategic collaboration with University Hospital Zurich (USZ) to deploy digital pathology platform AISight Dx, together with AIM-TumorCellularity (AIM-TC) to support tumour cell content (TCC) quantification in routine molecular workflows.

Researchers at WashU Medicine and their collaborators have created an immune cell atlas of multiple myeloma, a cancer of the bone marrow. The new resource could improve prognosis and guide development of new immunotherapies.

More women with ovarian cancer could be diagnosed earlier under proposed new NICE guidance that replaces a one-size-fits-all blood test threshold with personalised, age-based criteria.

Noul Co, a company specialising in AI-powered blood and cancer diagnostics, recently showcased its AI-based cervical cancer diagnostic solution, miLab CER at the technology event CES 2026.

Medical Wire & Equipment (MWE) has announced that the Fecal Transwab with Liquid Cary Blair Medium Specimen Collection and Transport System has received FDA 510(k) clearance for the preservation and transport of faecal specimens for microbiological testing in clinical laboratories.

Precision medicine firm Sophia Genetics and The University of Texas MD Anderson Cancer Center have announced a strategic collaboration that unites Sophia’s AI-powered analytics with MD Anderson's clinical and scientific expertise.

US diagnostic firm CorePlus has announced the implementation of AIxURO, a state-of-the-art software solution that utilises artificial intelligence to significantly improve the accuracy and efficiency of bladder cancer detection.

A groundbreaking international study has shown that Alzheimer's disease biomarkers can be accurately detected using simple finger-prick blood samples.